NEW · Pharmaceuticals
MRK
Merck & Co Inc · $333.49B
152.23
+12.62%
Price
23 sessions shownTechnicals
from daily closesRSI · 14 day
87.5
Avg true range · 14d
2.85%
Volatility · 20d annualised
44.4%
Trend · 20d vs 50d
—
vs 20-day average
15.13%
vs 50-day average
—
vs 200-day average
—
200-day average
—
Internals
where it sits, and how hard it is being traded52-week low
77.58
52-week high
137.98
Volume vs its 20-day avg
3.49×
Beta vs the market
0.20
Sitting 124% of the way up its 52-week range (77.58 → 137.98)
Swings
prices it actually turned at — highest or lowest of the surrounding 11 sessionsTurned down · Jul 28
135.05
Turned up · Aug 4
126.22
Fundamentals
P/E
103.86
Fwd P/E
—
P/S
4.95
P/B
4.97
EV/EBITDA
24.76
ROE
17.9%
ROA
7.0%
Gross margin
77.3%
Net margin
—
Debt / equity
0.94
Rev growth
4.6%
EPS growth
8.4%
Earnings
Next report
Oct 29, 2026
EPS expected
2.25
Beat in last 4
4 of 4
2026-06-30reported -0.13 vs -0.27 expected+52.3%
2026-03-31reported -1.28 vs -1.52 expected+16.0%
2025-12-31reported 2.09 vs 2.03 expected+3.0%
2025-09-30reported 2.68 vs 2.37 expected+13.1%
Analyst coverage
36 analysts · as of 2026-08-01Strong buy
9
Buy
16
Hold
11
Sell
0
Strong sell
0
News
stories naming this company, last 21 daysEvery figure here is measured from live market data as of Aug 19, 08:13 PM. Nothing is estimated or filled in — where a figure shows — the source had no value for it, and a section you don’t see had no data at all. This describes what the market has already done. It is not a forecast, and not financial advice.